What a PI-RADS 3 Score Means: Biopsy or Not?

A PI-RADS 3 score is the one prostate MRI result that satisfies no one. It isn’t the reassuring all-clear of a 1 or 2, and it isn’t the strong warning of a 4 or 5. It sits on the fence — radiologists call it equivocal, which is a precise way of saying the scan cannot tell whether what it sees is cancer or something harmless. If your report came back with this number, you are probably staring at it wondering whether you need a biopsy or whether you can wait. That uncertainty is the whole point of this article. A PI-RADS 3 result is common, the true cancer risk attached to it is lower than most men fear, and there is usually one extra number — your PSA density — that settles the biopsy question more cleanly than the MRI alone. For how prostate MRI fits into modern screening, see our Prostate Health Hub. Here, I’ll walk through exactly what the score means and what I’d advise you to do next.

What a PI-RADS 3 score actually means

PI-RADS stands for the Prostate Imaging Reporting and Data System — a standardized way radiologists score a prostate MRI from 1 to 5. Each number estimates one thing: the probability that a clinically significant cancer is hiding in what the scan shows. A 1 means that probability is very low; a 5 means it is very high. The American Urological Association recommends an MRI before a first biopsy and asks radiologists to report it using exactly this PI-RADS scale.[1]

A PI-RADS 3 lands in the true middle, and the official wording for it is equivocal. That is radiology’s honest admission that the area in question could be early cancer — or could be something completely benign. A patch of inflammation (prostatitis), a benign enlargement nodule (BPH), or normal transition-zone tissue can all look suspicious on the same images. The scan alone cannot separate them.

This is also why the MRI now comes before the biopsy rather than after it: it lets your urologist target only the areas that look concerning instead of sampling the gland blindly. For the full picture of that shift in how prostate cancer is diagnosed, the related read below is the place to start.

How likely is cancer with a PI-RADS 3 result?

Before talking about risk, one term has to be clear. Clinically significant cancer means a tumor graded Grade Group 2 or higher — Gleason 3+4=7 and above. That is the kind worth finding and treating. Grade Group 1 disease, by contrast, is so slow-moving that it is often safely monitored rather than removed, which is why not every cancer a biopsy finds actually changes your life.

So how often does a PI-RADS 3 lesion hide significant cancer? Across large studies, the answer clusters around 1 in 5 — roughly 15 to 20 percent.[2][4] Put the other way: four out of five men with this score do not have significant cancer. That is reassuring, but a 1-in-5 chance is still too high to simply ignore — which is the exact bind a PI-RADS 3 puts everyone in.

If your PSA sat in the 4 to 10 ng/mL gray zone that usually triggers the scan, the same lesson holds: the absolute number rarely settles things alone. You can estimate your overall risk from age, PSA, and family history — but for a PI-RADS 3 specifically, one measurement does more work than any other.

PSA density: the number that usually decides

That measurement is PSA density. It is simply your total PSA divided by the size of your prostate — its volume in cubic centimeters, which the MRI has already measured. A PSA of 6 means something very different in a small 30 cc gland than in a bulky 90 cc one. In the small gland the PSA is concentrated (high density); in the large gland it is diluted by benign tissue (low density).

The number that matters is 0.15 ng/mL per cc. Below roughly 0.15, the chance that a PI-RADS 3 lesion harbors significant cancer falls to about 14 percent.[2] At or above 0.15, that risk roughly doubles, and PSA density at this cutoff has held up as a consistent predictor of significant disease in men with a PI-RADS 3 lesion.[3] This single ratio is usually what tips a PI-RADS 3 toward biopsy or toward watchful repeat imaging.

If you want to see how the two values combine, a PI-RADS and PSA density biopsy-decision tool walks through the same thresholds I use in clinic.

PI-RADS 3 — should you get a biopsy?

A PI-RADS 3 does not put you on an automatic path to biopsy. The AUA guideline supports targeted biopsy of suspicious lesions scored 3 to 5, but it is precisely at a 3 that shared decision-making carries the most weight.[1] The choice comes down to stacking the rest of your risk picture on top of that single score.

Factors that push toward a biopsy now:

• PSA density of 0.15 ng/mL per cc or higher
• An abnormal digital rectal exam
• A first-degree relative with prostate cancer, or a known BRCA mutation
• No previous biopsy combined with a steadily rising PSA

Factors that support a repeat MRI instead:

• PSA density comfortably below 0.10 to 0.15
• A large, benign-feeling gland that explains the PSA
• One or more prior negative biopsies
• Older age or other health conditions that limit the benefit of finding slow-growing disease

When the picture leans low-risk, a repeat MRI in 6 to 12 months alongside PSA monitoring is a legitimate, guideline-consistent path — not a cop-out. If you do proceed, it helps to know what the biopsy itself involves and to ask about a transperineal route, which lowers the risk of serious infection.

What to do next if your report says PI-RADS 3

If your report says PI-RADS 3, here is what I would do in your position — concretely, not vaguely.

• Get your PSA density. Ask for your most recent PSA and the prostate volume on the MRI report, then divide one by the other. If it is 0.15 or higher, raise that with your urologist directly.
• Ask the specific question: “Given my PSA density and risk factors, do you recommend a targeted biopsy now, or a repeat MRI in 6 to 12 months?” Make them choose between the two named paths.
• Ask about the biopsy route. A transperineal approach carries a lower risk of serious infection than the older transrectal method — worth requesting if you do go ahead.
• Read the report wording yourself. Words like “lesion” or “focus” are descriptive, not a diagnosis — the score and your PSA density mean more than any single word.

A PI-RADS 3 is also a good prompt to confirm the rest of your screening is current. Our men’s health checklist for the over-40s covers what else belongs on the list at your age.

Frequently asked questions about a PI-RADS 3 score

Dr. Muhammad Khalid

MBBS · FCPS (Urology) · MCPS (Gen. Surgery) · CHPE · CRSM · IMC #539472

Specialist urologist with 11+ years of clinical experience across tertiary teaching hospitals. Trained at Lady Reading Hospital and Khyber Teaching Hospital, Peshawar. Author of 5 peer-reviewed international publications in Cureus, WJSA, and AJBS. Procedural expertise: URS, PCNL, RIRS, TURP, TURBT, and major open urological surgery. Full profile →

This article is for educational purposes only and does not constitute medical advice. Always consult your physician or urologist for diagnosis and treatment decisions specific to your condition.